文献速递乳腺乳腺X线US

致密乳腺患者的筛查:乳腺X线摄影、人工智能与补充超声的比较

Screening in Patients With Dense Breasts: Comparison of Mammography, Artificial Intelligence, and Supplementary Ultrasound.
PubMed 文献 · AJR Am J Roentgenol · 2023-07-26

该回顾性研究纳入1325例致密乳腺女性,比较单独乳腺X线摄影、单独人工智能、单独超声及乳腺X线摄影联合人工智能和/或超声的筛查性能,发现乳腺X线摄影联合补充超声相比联合人工智能或联合两者具有更高的准确性和特异度及更低的召回率,未能显示人工智能在补充超声基础上额外获益。

要点

  • 致密乳腺患者中,乳腺X线摄影联合超声的准确率89.2%、特异度89.1%、召回率11.7%。
  • 乳腺X线摄影联合超声与联合人工智能或联合两者相比,准确率更高、特异度更高、召回率更低。
  • 单独人工智能相比单独乳腺X线摄影或单独超声,召回率更高、特异度和准确率更低。

核心结论

  • 乳腺X线摄影联合补充超声相比乳腺X线摄影联合人工智能及联合超声和人工智能,显示出更高的准确率、更高的特异度和更低的召回率。
  • 研究结果未能显示人工智能在致密乳腺患者接受补充乳腺超声的筛查乳腺X线摄影中有获益。

研究设计与样本

  • 回顾性研究纳入1325例致密乳腺女性(平均年龄53岁),于2017年1月至2017年12月间1个月内接受筛查乳腺X线摄影和补充乳腺超声。
  • 91.2%和91.8%的病例分别有既往乳腺X线摄影和既往超声检查可供比较。
  • 乳腺X线摄影和超声由15名放射科医生(5名正式职员,10名研究员)中的一名解读,临床报告用于本分析。
  • 使用商业人工智能工具回顾性评估乳腺X线摄影是否存在癌症,采用广义估计方程比较筛查性能。
  • 良性诊断要求影像稳定24个月或更长。

诊断标准与关键数值

  • 共诊断12例癌症(6例浸润性导管癌,6例导管原位癌)。
  • 乳腺X线摄影、单独人工智能、单独超声的癌症检出率(每1000例患者)分别为6.0、6.8、6.0(均p > .05)。
  • 乳腺X线摄影、单独人工智能、单独超声的召回率分别为4.4%、11.9%、9.2%(均p < .05)。
  • 乳腺X线摄影、单独人工智能、单独超声的敏感度分别为66.7%、75.0%、66.7%(均p > .05)。
  • 乳腺X线摄影、单独人工智能、单独超声的特异度分别为96.2%、88.7%、91.3%(均p < .05),准确率分别为95.9%、88.5%、91.1%(均p < .05)。

临床应用与阅片要点

  • 原文结论指出,在致密乳腺患者接受补充乳腺超声的筛查乳腺X线摄影中,人工智能未能显示获益。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Screening mammography has decreased performance in patients with dense breasts. Supplementary screening ultrasound is a recommended option in such patients, although it has yielded mixed results in prior investigations. OBJECTIVE. The purpose of this article is to compare the performance characteristics of screening mammography alone, standalone artificial intelligence (AI), ultrasound alone, and mammography in combination with AI and/or ultrasound in patients with dense breasts. METHODS. This retrospective study included 1325 women (mean age, 53 years) with dense breasts who underwent both screening mammography and supplementary breast ultrasound within a 1-month interval from January 2017 to December 2017; prior mammography and prior ultrasound examinations were available for comparison in 91.2% and 91.8%, respectively. Mammography and ultrasound examinations were interpreted by one of 15 radiologists (five staff; 10 fellows); clinical reports were used for the present analysis. A commercial AI tool was used to retrospectively evaluate mammographic examinations for presence of cancer. Screening performances were compared among mammography, AI, ultrasound, and test combinations, using generalized estimating equations. Benign diagnoses required 24 months or longer of imaging stability. RESULTS. Twelve cancers (six invasive ductal carcinoma; six ductal carcinoma in situ) were diagnosed. Mammography, standalone AI, and ultrasound showed cancer detection rates (per 1000 patients) of 6.0, 6.8, and 6.0 (all p > .05); recall rates of 4.4%, 11.9%, and 9.2% (all p < .05); sensitivity of 66.7%, 75.0%, and 66.7% (all p > .05); specificity of 96.2%, 88.7%, and 91.3% (all p < .05); and accuracy of 95.9%, 88.5%, and 91.1% (all p < .05). Mammography with AI, mammography with ultrasound, and mammography with both ultrasound and AI showed cancer detection rates of 7.5, 9.1, and 9.1 (all p > .05); recall rates of 14.9, 11.7, and 21.4 (all p < .05); sensitivity of 83.3%, 100.0%, and 100.0% (all p > .05); specificity of 85.8%, 89.1%, and 79.4% (all p < .05); and accuracy of 85.7%, 89.2%, and 79.5% (all p < .05). CONCLUSION. Mammography with supplementary ultrasound showed higher accuracy, higher specificity, and lower recall rate in comparison with mammography with AI and in comparison with mammography with both ultrasound and AI. CLINICAL IMPACT. The findings fail to show benefit of AI with respect to screening mammography performed with supplementary breast ultrasound in patients with dense breasts.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Lee SE, Yoon JH, Son NH, et al. Screening in Patients With Dense Breasts: Comparison of Mammography, Artificial Intelligence, and Supplementary Ultrasound. AJR Am J Roentgenol. 2023. PMID: 37493324. doi:10.2214/AJR.23.29655

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。